XML 81 R62.htm IDEA: XBRL DOCUMENT v3.26.1
EQUITY (Narrative) (Details)
 1 Months Ended 12 Months Ended
Jan. 31, 2025
USD ($)
$ / shares
shares
Nov. 30, 2024
USD ($)
$ / shares
shares
Apr. 30, 2024
USD ($)
$ / shares
shares
Aug. 31, 2023
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
Share
₪ / shares
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2025
₪ / shares
Dec. 31, 2025
USD ($)
Share
shares
Dec. 31, 2024
₪ / shares
Dec. 31, 2024
USD ($)
Share
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Change in fair value             $ 454,000 $ 11,427,000            
Share issue related cost             702,000 669,000   $ 0        
Gross proceeds             $ 13,894,000 $ 16,357,000   $ 14,089,000        
Remaining authorized unissued ordinary shares | shares                       233,400,000    
Option outstanding | Share                       311,967,000   141,634,245
Weighted average contractual life             8 years 8 months 4 days 7 years 7 months 6 days            
Risk-free interest rate (%)             4.00% 4.00%   4.00%        
Average standard deviation             93.00% 73.00%   69.00%        
Remaining unrecognized deferred compensation expense             $ 1,200,000              
Compensation cost             1,871,000 $ 2,811,000   $ 3,742,000        
Weighted average exercise price outstanding | ₪ / shares                     ₪ 0.1      
ADSs [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Exercise Price Of Share Issued | $ / shares       $ 85.44                    
Share issue related cost       $ 900,000                    
Gross proceeds       $ 14,600,000                    
Number of shares issued | shares       170,728                    
ADSs [Member] | IFRS 15 [member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Share issue related cost       $ 700,000                    
Recognized as equity       $ 12,000,000                    
H C Wainwright And Co Llc [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Gross proceeds               9,200,000            
Sale of stock | shares           825,010                
Aggregate offering price           $ 25,000,000                
Percentage of commission on sales agreement           3.00%                
H C Wainwright And Co Llc [Member] | ADSs [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Gross proceeds             $ 5,000,000              
Sale of stock | shares             772,264              
2003 Plan [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares                       326,757,000    
Option vested and exercised             To date, each PSU grant has had between three to five performance goals on which vesting is based, each such goal being either a specified Company milestone and or the success of a specific project, with vesting of 20-40% on the achievement of each goal.              
Option vested             8,787,600              
Performance Shares Unit [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Option outstanding | Share                 12,219,465     8,126,400   4,010,670
Weighted average exercise price outstanding | ₪ / shares                 ₪ 0.1   0.1   ₪ 0.1  
Performance Shares Unit [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Option outstanding | Share                       21,240,000    
Weighted average exercise price outstanding | ₪ / shares                     0      
Warrant [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Exercise Price Of Share Issued | $ / shares   $ 21.85 $ 32   $ 44                  
Amount allocated to warrant   $ 27,000 $ 642,000   $ 800,000                  
Change in fair value   $ 2,721,000 $ 6,250,000   $ 9,100,000   $ 24,000 478,000            
Risk-free interest rate (%)   4.19% 4.21%   3.62%   3.47%              
Average standard deviation   84.50% 84.70%   82.50%   101.32%              
Aggregate offering price   $ 9,000,000 $ 6,000,000                      
Registered direct offerings sales | shares   308,749 187,500   340,909                  
Warrants expiration period     five years   five years                  
Exercise price of warrants | $ / shares     $ 32   $ 46                  
Proceeds from warrant issue, net   $ 8,900,000 $ 5,400,000                      
Warrant [Member] | Initial recognition [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Fair value of the warrants                       $ 250,000    
Warrant [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Change in fair value             $ 5,571,000 298,000            
Fair value of the warrants                       $ 171,000   $ 679,000
Risk-free interest rate (%)             3.55%              
Average standard deviation             94.00%              
Warrantt [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Change in fair value             $ 102,000 745,000            
Risk-free interest rate (%)             3.55%              
Average standard deviation             96.00%              
Pre Funded Warrants [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Exercise Price Of Share Issued | $ / shares   $ 0.004                        
Warrants issued to purchase shares | shares             226,392              
Warrants expiration period   four years                        
Exercise price of warrants | $ / shares   $ 23.6                        
Changes In Fair Value Recorded As A Non-operating Income             $ 643,000 $ 1,976,000            
Beneficially Own In Excess   4.99%                        
Consultants [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Number of shares issued | shares                 17,836,200          
Weighted average exercise price | ₪ / shares                 ₪ 0.36          
Option vested and exercised             The options to consultants generally vest over four years and may be exercised for periods of between five and ten years.              
Option outstanding | Share                       14,790,000    
Weighted average contractual life             9 years 9 months 18 days              
Weighted average exercise price outstanding | ₪ / shares                     ₪ 0.03      
Investors [Member] | Warrant [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Warrants issued to purchase shares | shares   205,893 187,500   340,909                  
Placement Agent's Designees [Member] | Warrant [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Amount allocated to warrant         $ 400,000                  
Aggregate offering price         $ 15,000,000                  
Warrants issued to purchase shares | shares         17,045                  
Warrants expiration period         five years                  
Exercise price of warrants | $ / shares         $ 55                  
Proceeds from warrant issue, net         $ 13,500,000                  
Highbridge Capital Management Llc [Member] | Warrant [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Exercise Price Of Share Issued | $ / shares   $ 21.86                        
Registered direct offerings sales | shares   103,037                        
January 2025 Offering [Member] | ADSs [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Exercise Price Of Share Issued | $ / shares $ 8                          
Registered direct offerings sales | shares 858,303                          
Warrants issued to purchase shares | shares 1,250,000                          
January 2025 Offering [Member] | Warrant [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Amount allocated to warrant $ 700,000                          
Change in fair value $ 10,400,000           $ 1,878,000              
Risk-free interest rate (%) 4.41%           3.64%              
Average standard deviation 90.20%           91.00%              
Fair value of the ordinary warrants was adjusted amount $ 1,400,000                          
Changes In Fair Value Recorded As A Non-operating Income             $ 7,204,000              
January 2025 Offering [Member] | Pre Funded Warrants [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Exercise Price Of Share Issued | $ / shares $ 7.996                          
Registered direct offerings sales | shares 391,697                          
Exercise price of other equity instruments exercisable | $ / shares $ 0.004                          
Warrants expiration period five years                          
Exercise price of warrants | $ / shares $ 8                          
Beneficially Own In Excess 4.99%                          
January 2025 Offering [Member] | Pre Funded Warrants [Member] | Placement Agent [Member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Proceeds from public offering, gross $ 10,000,000                          
Warrants issued to purchase shares | shares 62,500                          
Warrants expiration period five years                          
Exercise price of warrants | $ / shares $ 10                          
Warrants offering consideration $ 500,000                          
Proceeds From Exercise Of Warrants After Deducting Fees And Expenses $ 8,900,000                          
Warrants [member]                            
Disclosure of terms and conditions of share-based payment arrangement [line items]                            
Fair value of the warrants                       $ 2,174,000    
Warrants issued to purchase shares | shares             63,636